Cargando…
Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission
This study aimed to investigate the cutoff value of leucine-rich alpha-2 glycoprotein (LRG) in predicting active intestinal ultrasonography (IUS) findings in patients with Crohn’s disease (CD) in clinical remission. Data were retrospectively collected from patients with CD evaluated using LRG and un...
Autores principales: | Nasuno, Masanao, Shimazaki, Hiroshi, Nojima, Masanori, Hamada, Takahito, Sugiyama, Kohei, Miyakawa, Maki, Tanaka, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419375/ https://www.ncbi.nlm.nih.gov/pubmed/37565885 http://dx.doi.org/10.1097/MD.0000000000034628 |
Ejemplares similares
-
Predicting a rapid response to adalimumab treatment and favorable short-term outcomes through the high platelet count in patients with ulcerative colitis: A multicenter retrospective cohort study
por: Sakemi, Ryosuke, et al.
Publicado: (2020) -
Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission
por: Miyazu, Takahiro, et al.
Publicado: (2021) -
Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms?
por: Tocia, Cristina, et al.
Publicado: (2021) -
Quality of life among patients with autoimmune hepatitis in remission: A comparative study
por: Takahashi, Atsushi, et al.
Publicado: (2020) -
The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report
por: Sugiyama, Yuya, et al.
Publicado: (2023)